ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s stock price shot up 0.8% during mid-day trading on Monday . The company traded as high as C$6.70 and last traded at C$6.50. 19,980 shares traded hands during trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The firm has a market capitalization of C$162.08 million and a price-to-earnings ratio of -7.30. The company has a fifty day moving average of C$6.50 and a two-hundred day moving average of C$6.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Read Stock Charts for Beginners
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What is a support level?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Russell 2000 Index, How Investors Use it For Profitable Trading
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
